Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer

Conclusion: Anti-cancer treatment prolongs survival and time to MPE re-intervention in patients with lung cancer, though the lifetime burden of pleural re-intervention was not significantly reduced. Early MPE control measures were required to reduce the need of pleural re-intervention.

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Lui, M.-S. M., Chiang, K.-Y., Ho, C.-M. J., Tam, C.-C. T., Lam, C.-L., Lee, Y.-C. G., Ip, S.-M. M. Tags: Pleural and mediastinal malignancies Source Type: research